UK Experimental AMR Payment Program “On Track”

Health authorities in the UK remain on track with their program for testing a "pull" reward incentive mechanism as a way to both ensure adequate supply of antibiotics - a drug class that is fast ebbing away – while stimulating innovation for new antimicrobial drugs, a process that will also use health technology evaluations of the added value from any new antimicrobial, one of the project’s team leaders told Scrip.

The AMR ‘develop and test’ program, which first launched last summer, seeks to find a balance between supply and demand that reflects the fact that antibiotics tend to be for...